For decades, the National Health Service (NHS) has operated under a persistent, structural paradox: the mandate to innovate is constantly stifled by the rigidity of capital funding cycles. As England embarks on a bold 10-year health plan—aiming for a "digital-by-default" future—it has become increasingly clear that traditional procurement methods are no longer fit for purpose.
Stephen McMillan, Strategic Partnerships Leader at Philips, believes that a paradigm shift is not just necessary, but finally within reach. By moving away from transactional asset purchasing toward sophisticated, service-based financing, the NHS is beginning to dismantle the barriers that have historically kept cutting-edge technology out of the hands of clinicians.
The Core Challenge: The "Capital Constraint" Trap
To understand the urgency of this shift, one must first understand the "Capital Department Expenditure Limit" (CDEL). In the NHS, funding is often bifurcated into revenue (day-to-day operations) and capital (major equipment, infrastructure, and technology).
For years, the standard approach to procuring a piece of high-value equipment—such as an MRI scanner or an interventional radiology suite—was to draw from limited capital reserves. If a trust lacked the cash, the project stalled. Even when trusts utilized operating leases to spread costs, the 2022 implementation of IFRS 16 accounting standards changed the playing field. Under these rules, most leases must be recognized on the balance sheet, effectively eating into a trust’s precious CDEL allowance.
"NHS organisations have always faced a lack of capital," McMillan explains. "We’ve never been in a situation where there’s been money to throw around, unless it’s end-of-year surplus that must be spent. For a trust looking at a £10 million managed service agreement over 10 years, they previously had to recognize a significant portion of that capital up-front. If they didn’t have the CDEL, the project was dead on arrival."
Chronology of a Financial Evolution
The journey toward modern healthcare financing has been slow, but the trajectory is now accelerating.
- The Era of Conventional Leasing (1990s–2010s): For over 20 years, Philips and other industry partners provided standard operating and finance leases. These were effective for their time but remained fundamentally transactional. They were "no different from anyone else’s," as McMillan notes.
- The Regulatory Shift (2022): The adoption of IFRS 16 sent ripples through the NHS finance community. Suddenly, the "off-balance sheet" benefits of operating leases vanished, forcing trusts to account for the long-term liability of their equipment in their capital budgets.
- The Innovation Response (2023–Present): In response to the tighter regulatory environment, industry leaders like Philips began engineering complex, service-led models. By shifting the contract from "buying equipment" to "buying a service," the financial burden moved from capital expenditure (CAPEX) to operating expenditure (OPEX), providing a vital release valve for stretched trusts.
Supporting Data: Why "Pay-Per-Use" Matters
The core of the new financial architecture lies in "Pay-Per-Use" and "As-a-Service" models. These are not merely payment plans; they are risk-sharing instruments designed to align with actual patient demand.
The Mechanism of Flexibility
Under a Pay-Per-Use model, a trust does not pay a flat monthly fee for an MRI machine. Instead, they pay based on usage volume.
- Risk Mitigation: If patient throughput is lower than projected, the trust’s costs scale down accordingly.
- The "Ceiling" Protection: Conversely, if usage surges, the agreement includes caps to protect the trust from unmanageable overspends.
- VAT Recovery: Through carefully structured, supplier-led service provision, these models often allow for VAT recovery, effectively lowering the total cost of ownership—a success story for trusts that have integrated these models effectively.
The "Fleet" Approach
While initially designed for "big-ticket" items like CT scanners, the model is now being applied to fleets of smaller equipment. For example, a hospital needing 20 ultrasound machines can aggregate them into a single enterprise-wide service agreement. This consolidates administrative overhead and creates a predictable, manageable cost structure across the entire facility.
Official Perspective: A Culture Shift
The current 10-year health plan for England signals a departure from the austerity-driven mindset of the past. There is a newfound political and administrative appetite for financial innovation.
"For the first time in many years, the use of private financing no longer seems to be associated with something negative," McMillan observes. "The government and the NHS are opening the door to more levels of financial innovation. This allows us to have the conversation about financing at the start of the planning process, rather than as an afterthought when the budget is already exhausted."
This sentiment is echoed by trusts that have already piloted these models, such as the Mid and South Essex Foundation Trust, which utilized pay-per-use to modernize their interventional radiology capabilities.
Implications for the Future of Care
The shift toward these flexible models has profound implications for the digital and technological maturity of the NHS.
1. Future-Proofing via "As-a-Service"
Technology in healthcare is evolving at an exponential rate, particularly with the integration of Artificial Intelligence (AI). Traditional procurement—buying a machine and keeping it for 10 years—is a recipe for obsolescence. Service-based models include built-in maintenance and, crucially, technology upgrades. This ensures that a trust’s equipment remains state-of-the-art without requiring a new capital injection every few years.
2. A Move Toward "Whole Enterprise" Partnership
The relationship between vendors and the NHS is moving away from a transactional buyer-seller dynamic toward a genuine, long-term partnership. When Philips, in collaboration with global financier DLL, enters a contract, the focus is on enterprise-wide productivity.
"We don’t look at this from a technological perspective," says McMillan. "We look at it from a whole enterprise perspective. How can we be your partner and help you transform? As things flex and change, or new technology comes in, our customers can take advantage of that long-term partnership."
3. Shared Risk, Shared Success
The "As-a-Service" model implicitly shares risk. If the equipment fails to deliver on its promise of efficiency or uptime, the provider has a vested interest in fixing it immediately, as the contract is tied to the service provided rather than the hardware sold. This creates a powerful incentive for the vendor to ensure the trust remains as productive as possible.
Conclusion: The Path Ahead
The transition toward flexible, service-based financing is more than a creative accounting solution; it is an essential component of a sustainable healthcare system. By decoupling clinical innovation from the constraints of rigid, cyclical capital budgets, the NHS can move closer to its goal of being "digital by default."
As trusts across the UK navigate the complexities of IFRS 16 and the urgent need for modernization, the ability to adopt "as-a-service" models will likely separate the high-performing, agile trusts from those left struggling with legacy infrastructure.
For Stephen McMillan and the team at Philips, the mission is clear: to ensure that when a hospital needs the latest life-saving technology, the primary question is no longer "How can we afford this capital expenditure?" but rather "How can we use this technology to improve patient outcomes today?"
In the new era of healthcare partnership, financing is no longer the barrier to progress—it is the engine that drives it.
For more information on how these financial models can support your trust’s digital transformation, visit Philips Healthcare or follow their latest updates on LinkedIn.
